Infliximab 100 mg pó inj (BIOSSIMILAR) REMSIMA, Adalimumab 80mg/0.8ml (Biossimilar-Pharmakern) sol inj caneta 0.8ml SC e Adalimumab 40mg/0.4ml (Biossimilar-Pharmakern) sol inj caneta 0.4ml SC

ID 11316206 · Portal BASE
Price
Base Price
€322,750 .00
Effective Price
€322,750 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa Portugal, Lisboa, Lisboa Portugal, Lisboa, Lisboa
Bidder Count
—
Winner
PHARMAKERN PORTUGAL, LDA.
NIF 507002571
Company
Dates
Publication
29 Mar 2025
Celebration
28 Mar 2025
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api · synced 2026-04-17